THE CURRENT STATUS OF IMMUNOMODULATORY APPROACHES IN THE TREATMENT OF CHRONIC HEPATITIS B

Chronic hepatitis B is a major global health concern caused by the hepatitis B virus (HBV) and is associated with persistent liver inflammation, progressive fibrosis, liver cirrhosis, and an increased risk of hepatocellular carcinoma. The development and persistence of chronic HBV infection are determined not only by the biological characteristics of the virus but also by the complex interactions between the virus and the host's innate and adaptive immune responses. Therefore, in addition to suppressing viral replication, the modulation of antiviral immune responses has become an important area of research in the management of chronic hepatitis B. This article reviews the immunopathogenesis of chronic hepatitis B, the role of interferon-alpha-based therapy, and emerging immunotherapeutic strategies investigated in combination with nucleos(t)ide analogues. Particular attention is given to therapeutic vaccines, immune checkpoint inhibitors, and approaches aimed at restoring HBV-specific T-cell responses.

Authors

Institutions

Publication Details

Journal
International journal of technology and academic research
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24342787
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

THE CURRENT STATUS OF IMMUNOMODULATORY APPROACHES IN THE TREATMENT OF CHRONIC HEPATITIS B

Worldly Knowledge Publishing Centre, Khoshimova Dildora, Ahmadaliyeva Nasiba, Zokirov Mironshokh et al.
International journal of technology and academic research
Hepatitis B Virus Studies
article

THE CURRENT STATUS OF IMMUNOMODULATORY APPROACHES IN THE TREATMENT OF CHRONIC HEPATITIS B

Worldly Knowledge Publishing Centre, Khoshimova Dildora, Ahmadaliyeva Nasiba, Zokirov Mironshokh, Nematov Khondamir, Eraliyeva Madina, Mukhiddin Numonjonov
article en

Abstract

Chronic hepatitis B is a major global health concern caused by the hepatitis B virus (HBV) and is associated with persistent liver inflammation, progressive fibrosis, liver cirrhosis, and an increased risk of hepatocellular carcinoma. The development and persistence of chronic HBV infection are determined not only by the biological characteristics of the virus but also by the complex interactions between the virus and the host's innate and adaptive immune responses. Therefore, in addition to suppressing viral replication, the modulation of antiviral immune responses has become an important area of research in the management of chronic hepatitis B. This article reviews the immunopathogenesis of chronic hepatitis B, the role of interferon-alpha-based therapy, and emerging immunotherapeutic strategies investigated in combination with nucleos(t)ide analogues. Particular attention is given to therapeutic vaccines, immune checkpoint inhibitors, and approaches aimed at restoring HBV-specific T-cell responses.

International journal of technology and academic research
Andijan State Medical Institute (UZ), Kokand State University (UZ)
Good health and well-being
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon